GB828766A - Medicine for reducing cholesterol level of the blood - Google Patents

Medicine for reducing cholesterol level of the blood

Info

Publication number
GB828766A
GB828766A GB10315/58A GB1031558A GB828766A GB 828766 A GB828766 A GB 828766A GB 10315/58 A GB10315/58 A GB 10315/58A GB 1031558 A GB1031558 A GB 1031558A GB 828766 A GB828766 A GB 828766A
Authority
GB
United Kingdom
Prior art keywords
medicine
blood
cholesterol level
reducing cholesterol
hypercholesterolamia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB10315/58A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of GB828766A publication Critical patent/GB828766A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A unit dosage form of a medicament for treating hypercholesterolamia, for example a tablet or capsule, comprises from 50 to 300 mg. of 4 - (3,5 - diiodo - 4 - hydroxy - phenoxy) - 3,5 - diiodobenzoic acid in admixture with a solid pharmaceutical diluent.
GB10315/58A 1957-10-28 1958-03-31 Medicine for reducing cholesterol level of the blood Expired GB828766A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US828766XA 1957-10-28 1957-10-28

Publications (1)

Publication Number Publication Date
GB828766A true GB828766A (en) 1960-02-24

Family

ID=22174010

Family Applications (1)

Application Number Title Priority Date Filing Date
GB10315/58A Expired GB828766A (en) 1957-10-28 1958-03-31 Medicine for reducing cholesterol level of the blood

Country Status (1)

Country Link
GB (1) GB828766A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284971A (en) * 1992-07-16 1994-02-08 Syntex (U.S.A.) Inc. 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284971A (en) * 1992-07-16 1994-02-08 Syntex (U.S.A.) Inc. 4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents

Similar Documents

Publication Publication Date Title
GB828766A (en) Medicine for reducing cholesterol level of the blood
Pecknold et al. Lack of indication for use of antiparkinson medication: A follow-up study.
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
GB950162A (en) Medicines for the treatment of hepatic disorders
CA586002A (en) Means for administering medication orally into the respiratory organs
FR1056M (en) Pharmaceutical product intended for the treatment of circulatory disorders of the upper or lower limbs.
ES386130A1 (en) Aminoethanesulfonic acid derivative
GB976096A (en) Pharmaceutical compositions
ES352458A1 (en) Procedure for the preparation of a medication for proteoanabilizing action. (Machine-translation by Google Translate, not legally binding)
FR2576M (en) New drug, in particular for the treatment of blood coagulability disorders.
SU109348A1 (en) Method for expansion of coronary and peripheral vessels
GB1128372A (en) Injectable pharmaceutical compositions
ES383340A1 (en) P-(acetoacetamidoalkyl)benzenesulfonamide derivatives
Wang Amoxicillin/clavulanic-acid
GB892784A (en) Pharmaceutical compositions comprising 3-pyridine acetic acid
NL154217B (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS IN WHICH ONE PUTS 11-ALKOXY-3-KETOSTEROIDS WITH AN OXYGEN FUNCTION IN THE 17-PLACE IN MEDICAL USE FORM OF ADMINISTRATION, THE PREPARED MEDICINAL PRODUCTS, AS PREPARED MEDICINAL PRODUCTS, AS PREPARED PREPARATIONS.
GB953250A (en) Pharmaceutical compositions comprising diphospho-pyridine nucleotide or a derivative thereof
TATENO The Treatment of A Case of Stomath Cancer by Oriental Medicine
Matsukuma et al. A Case of Parrot's Pseudoparalysis
FR1829M (en) New drug, in particular for the treatment of blood coagulability disorders.
Tsushita Some Experiences of Hand Surgery
GB891445A (en) Pharmaceutical compositions comprising sulphonamido-thiadiazole derivatives
AU225630B2 (en) Pharmaceutical dosage unit adapted forthe treatment of hypercholesterolemia
GB994733A (en) New anabolically effective pharmaceutical preparations
ES276322A1 (en) Method for the treatment of the affection of drugs (Machine-translation by Google Translate, not legally binding)